Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McConnell

Showing results (211-220 of 234) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|October 25, 2016
Discovery of Novel Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2-p53 InteractionAndreas Gollner, Dorothea Rudolph, Heribert Arnhof, et al.
Oncotarget|March 18, 2020
Inducible knock-out of BCL6 in lymphoma cells results in tumor stasisStefanie Schlager, Carina Salomon, Sabine Olt, et al.
Journal of Medicinal Chemistry|February 12, 2019
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding FunctionsJohannes Popow, Heribert Arnhof, Gerd Bader, et al.
Molecular Cancer Therapeutics|February 7, 2020
Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor SurveillanceMarco H Hofmann, Rajeswaran Mani, Harald Engelhardt, et al.
Nature|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growthDongsung Kim, Lorenz Herdeis, Dorothea Rudolph, et al.
Journal of Medicinal Chemistry|October 27, 2022
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS<sup>G12C</sup> InhibitorJoachim Bröker, Alex G Waterson, Chris Smethurst, et al.
Journal of Medicinal Chemistry|September 12, 2018
Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RASTimothy R Hodges, Jason R Abbott, Andrew J Little, et al.
Chemmedchem|December 4, 2020
Getting a Grip on the Undrugged: Targeting β-Catenin with Fragment-Based MethodsDirk Kessler, Moriz Mayer, Stephan K Zahn, et al.
Communications Chemistry|January 19, 2026
Expanding the toolbox to develop IAP-based degraders of TEAD transcription factorsNishma Gupta, Nicole Trainor, Mona Radwan, et al.
Nature Communications|April 14, 2025
Drugit: crowd-sourcing molecular design of non-peptidic VHL bindersThomas Scott, Christian Alan Paul Smethurst, Yvonne Westermaier, et al.
Pageof 24

Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|October 25, 2016
Discovery of Novel Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2-p53 InteractionAndreas Gollner, Dorothea Rudolph, Heribert Arnhof, et al.
Oncotarget|March 18, 2020
Inducible knock-out of BCL6 in lymphoma cells results in tumor stasisStefanie Schlager, Carina Salomon, Sabine Olt, et al.
Journal of Medicinal Chemistry|February 12, 2019
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding FunctionsJohannes Popow, Heribert Arnhof, Gerd Bader, et al.
Molecular Cancer Therapeutics|February 7, 2020
Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor SurveillanceMarco H Hofmann, Rajeswaran Mani, Harald Engelhardt, et al.
Nature|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growthDongsung Kim, Lorenz Herdeis, Dorothea Rudolph, et al.
Journal of Medicinal Chemistry|October 27, 2022
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS<sup>G12C</sup> InhibitorJoachim Bröker, Alex G Waterson, Chris Smethurst, et al.
Journal of Medicinal Chemistry|September 12, 2018
Discovery and Structure-Based Optimization of Benzimidazole-Derived Activators of SOS1-Mediated Nucleotide Exchange on RASTimothy R Hodges, Jason R Abbott, Andrew J Little, et al.
Chemmedchem|December 4, 2020
Getting a Grip on the Undrugged: Targeting β-Catenin with Fragment-Based MethodsDirk Kessler, Moriz Mayer, Stephan K Zahn, et al.
Communications Chemistry|January 19, 2026
Expanding the toolbox to develop IAP-based degraders of TEAD transcription factorsNishma Gupta, Nicole Trainor, Mona Radwan, et al.
Nature Communications|April 14, 2025
Drugit: crowd-sourcing molecular design of non-peptidic VHL bindersThomas Scott, Christian Alan Paul Smethurst, Yvonne Westermaier, et al.
Pageof 24